Henry Schein (NASDAQ:HSIC) Stock Rating Reaffirmed by Barrington Research

Henry Schein (NASDAQ:HSIC)‘s stock had its “outperform” rating reiterated by Barrington Research in a note issued to investors on Friday, Benzinga reports. They currently have a $82.00 price target on the stock. Barrington Research’s price target suggests a potential upside of 15.25% from the company’s previous close.

A number of other equities research analysts have also recently issued reports on the stock. UBS Group dropped their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Evercore ISI dropped their target price on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a research report on Wednesday, August 7th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Piper Sandler reiterated an “overweight” rating and set a $86.00 target price on shares of Henry Schein in a research report on Friday, June 21st. Finally, Robert W. Baird dropped their target price on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Henry Schein currently has a consensus rating of “Hold” and a consensus target price of $77.10.

Henry Schein Trading Down 1.9 %

Shares of HSIC stock opened at $71.15 on Friday. Henry Schein has a 52-week low of $60.01 and a 52-week high of $82.63. The stock has a market cap of $9.11 billion, a price-to-earnings ratio of 24.04, a P/E/G ratio of 1.88 and a beta of 0.86. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. The firm has a fifty day moving average of $69.89 and a 200-day moving average of $70.35.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. During the same quarter in the prior year, the company posted $1.31 EPS. The business’s revenue was up .0% on a year-over-year basis. On average, equities research analysts forecast that Henry Schein will post 4.75 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 1.14% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Sanctuary Advisors LLC bought a new position in shares of Henry Schein in the 2nd quarter valued at about $351,000. Brandes Investment Partners LP boosted its stake in Henry Schein by 35.0% during the 2nd quarter. Brandes Investment Partners LP now owns 7,332 shares of the company’s stock worth $470,000 after acquiring an additional 1,900 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in Henry Schein by 84.0% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 3,189 shares of the company’s stock worth $204,000 after acquiring an additional 1,456 shares during the last quarter. Scientech Research LLC boosted its stake in Henry Schein by 271.6% during the 2nd quarter. Scientech Research LLC now owns 30,307 shares of the company’s stock worth $1,943,000 after acquiring an additional 22,152 shares during the last quarter. Finally, Lighthouse Investment Partners LLC bought a new position in Henry Schein during the 2nd quarter worth approximately $2,999,000. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.